0001070081-17-000096.txt : 20170602
0001070081-17-000096.hdr.sgml : 20170602
20170602185435
ACCESSION NUMBER: 0001070081-17-000096
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170531
FILED AS OF DATE: 20170602
DATE AS OF CHANGE: 20170602
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001070081
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 043416587
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
BUSINESS PHONE: 9082227000
MAIL ADDRESS:
STREET 1: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080-2449
FORMER COMPANY:
FORMER CONFORMED NAME: PTC THERAPEUTICS INC
DATE OF NAME CHANGE: 19980909
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Souza Marcio
CENTRAL INDEX KEY: 0001707657
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35969
FILM NUMBER: 17889517
MAIL ADDRESS:
STREET 1: C/O PTC THERAPEUTICS, INC.
STREET 2: 100 CORPORATE COURT
CITY: SOUTH PLAINFIELD
STATE: NJ
ZIP: 07080
4
1
wf-form4_149644405900854.xml
FORM 4
X0306
4
2017-05-31
0
0001070081
PTC THERAPEUTICS, INC.
PTCT
0001707657
Souza Marcio
C/O PTC THERAPEUTICS, INC.
100 CORPORATE COURT
SOUTH PLAINFIELD
NJ
07080
0
1
0
0
Chief Operating Officer
Common Stock
2017-05-31
4
A
0
30000
0
A
36457
D
Stock Option (Right To Buy)
12.53
2017-05-31
4
A
0
30000
12.53
A
2017-05-31
Common Stock
30000.0
30000
D
Stock Option (Right To Buy)
26.42
2024-07-31
Common Stock
30000.0
30000
D
Stock Option (Right To Buy)
51.0
2025-01-02
Common Stock
10525.0
10525
D
Stock Option (Right To Buy)
30.86
2026-01-03
Common Stock
16000.0
16000
D
Stock Option (Right To Buy)
12.64
2026-11-16
Common Stock
2000.0
2000
D
Stock Option (Right To Buy)
11.23
2027-01-02
Common Stock
23100.0
23100
D
Stock Option (Right To Buy)
12.92
2027-05-17
Common Stock
10000.0
10000
I
By Spouse
Restricted stock awarded to the Reporting Person vests in two equal annual installments over two years, commencing on May 31, 2018.
This option was granted on May 31, 2017, and vests in two equal annual installments over two years, commencing on May 31, 2018.
This option was granted on July 31, 2014 and vests over four years, with 25% of the shares underlying the option vested on July 31, 2015, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on October 31, 2015.
This option was granted on January 2, 2015 and vests over four years, with 25% of the shares underlying the option vested on January 2, 2016, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 2, 2016.
This option was granted on January 4, 2016 and vests over four years, with 25% of the shares underlying the option vested on January 4, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 4, 2017.
This option was granted on November 17, 2016, and vests over four years, with 25% of the shares underlying the option vesting on November 17, 2017, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on February 17, 2018.
This option was granted on January 3, 2017, and vests over four years, with 25% of the shares underlying the option vesting on January 3, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on April 3, 2018.
This option was granted on May 17, 2017, and vests over four years, with 25% of the shares underlying the option vesting on May 8, 2018, and an additional 6.25% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter, beginning on August 8, 2018.
Avraham S. Adler, attorney-in-fact
2017-06-02